1. A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours. (May 2017) Authors: de Jonge, Maja; de Weger, Vincent A.; Dickson, Mark A.; Langenberg, Marlies; Le Cesne, Axel; Wagner, Andrew J.; Hsu, Karl; Zheng, Wei; Macé, Sandrine; Tuffal, Gilles; Thomas, Koruth; Schellens, Jan H.M. Journal: European journal of cancer Issue: Volume 76(2017) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY. (11th November 2019) Authors: Heist, Rebecca S; Seto, Takashi; Han, Ji-Youn; Reguart, Noemi; Garon, Edward B; Groen, Harry J M; Tan, Daniel S W; Hida, Toyoaki; de Jonge, Maja; V Orlov, Sergey; Smit, Egbert F; Souquet, Pierre-Jean; Vansteenkiste, Johan; Le Mouhaer, Sylvie; Robeva, Anna; Waldron-Lynch, Maeve; Giovannini, Monica... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-51. ADJUVANT TROTABRESIB, A REVERSIBLE POTENT BROMODOMAIN AND EXTRATERMINAL INHIBITOR, PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: INTERIM RESULTS FROM A PHASE 1B DOSE-FINDING STUDY. (12th November 2021) Authors: Vieito, Maria; Simonelli, Matteo; de Vos, Filip; Moreno, Victor; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin; Del Conte, Gianluca; de Jonge, Maja; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna, Bishoy; Aronchik, Ida; Filvaroff, Ellen; Mendez, Cristin... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours. (July 2022) Authors: Schöffski, Patrick; Awada, Ahmad; de la Bigne, Anne-Marie; Felloussi, Zakia; Burbridge, Mike; Cantero, Frederique; Colombo, Riccardo; Maruzzelli, Sara; Ammattatelli, Katia; de Jonge, Maja; Aftimos, Philippe; Dumez, Herlinde; Sleijfer, Stefan Journal: European journal of cancer Issue: Volume 169(2022) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma. Issue 1 (28th October 2022) Authors: Vieito, Maria; Simonelli, Matteo; de Vos, Filip; Moreno, Victor; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin J; Del Conte, Gianluca; de Jonge, Maja; Martín-Soberón, Maria Cruz; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna, Bishoy; Aronchik, Ida; Fil... Journal: Neuro-oncology advances Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗